AAVantgarde

👥 61 employees💰 Last funded Nov 2025
Biotechnology Research🌐 aavantgarde.com
Website LinkedIn
AAVantgarde is a clinical stage, biotechnology company advancing best-in-class therapies for patients with inherited retinal diseases (IRDs). With a strong foundation in translational science and a commitment to clinical excellence, AAVantgarde is working to bring transformative therapies to patients.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United Kingdom
1
Italy
1
Frequently asked questions
Who invested in AAVantgarde?
AAVantgarde has 2 investors on record on gritt.io.
When did AAVantgarde last raise funding?
The most recent investment in AAVantgarde recorded on gritt.io was in November 2025.
What industry is AAVantgarde in?
AAVantgarde operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.